Page 117 - 2022-23-中国全科医学
P. 117

·2930· http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn


               综上,现有证据表明,疏风解毒胶囊辅助治疗 CAP 的疗                     [11]GUYATT G,OXMAN A D,AKL E A,et al. GRADE guidelines:1.
           效显著,安全性较好。但由于纳入的研究方法学质量欠佳,                               Introduction-GRADE evidence profiles and summary of findings
           仍需更多设计严谨的、多中心、大样本的 RCT 证据支持。                             tables[J]. J Clin Epidemiol,2011,64(4):383-394. DOI:
               作者贡献:杨江进行文章的构思与设计,Meta 分析的结                          10.1016/j.jclinepi.2010.04.026.
                                                               [12]郭国华,宋彬,朱传奇,等 . 疏风解毒胶囊联合头孢唑肟治
           果解读,撰写文章;李宣霖、王建新负责检索策略的制定、
                                                                    疗社区获得性肺炎临床观察[J]. 中华中医药杂志,2020,
           文献筛选、风险偏倚评估;谢洋负责文章的质量控制及审校;
                                                                    35(12):6437-6440.
           刘辉国、李素云、王明航负责项目的牵头、指南的实施和文
                                                                    GUO G H,SONG B,ZHU C Q,et al. Clinical observation of
           章的修订;杨江、王明航对文章整体负责。
                                                                    Shufeng Jiedu Capsule combined with Ceftizoxime in the treatment of
               本文无利益冲突。
                                                                    community-acquired pneumonia[J]. China Journal of Traditional
           参考文献                                                     Chinese Medicine and Pharmacy,2020,35(12):6437-6440.
           [1]OLSON G,DAVIS A M. Diagnosis and treatment of adults with   [13]李贤英,罗俊,卫艳 . 疏风解毒胶囊联合莫西沙星治疗非重症
               community-acquired pneumonia[J]. JAMA,2020,323(9):   社区获得性肺炎的疗效观察[J]. 中国中医急症,2020,29(6):
               885-886. DOI:10.1001/jama.2019.21118.                1088-1090. DOI:10.3969/j.issn.1004-745X.2020.06.041.
           [2]RAMIREZ J A,WIEMKEN T L,PEYRANI P,et al. Adults   [14]李颖,贾明月,张静,等 . 疏风解毒胶囊治疗社区获得性肺炎
               hospitalized with pneumonia in the United States:incidence,  临床疗效及对抗生素使用时间的影响[J]. 中华中医药杂志,
               epidemiology,and mortality[J]. Clin Infect Dis,2017,65(11):  2015,30(6):2239-2242.
               1806-1812. DOI:10.1093/cid/cix647.                   LI Y,JIA M Y,ZHANG J,et al. Evaluation on clinical efficacy
           [3]TORRES A,CILLÓNIZ C,BLASI F,et al. Burden of pneumococcal   of Shufeng Jiedu Capsule on community-acquired pneumonia and
               community-acquired pneumonia in adults across Europe:a literature   its influence on therapeutic time of antibiotic[J]. China Journal of
               review[J]. Respir Med,2018,137:6-13. DOI:10.1016/j.  Traditional Chinese Medicine and Pharmacy,2015,30(6):
               rmed.2018.02.007.                                    2239-2242.
           [4]GBD Mortality and Causes of Death Collaborators. Global,regional,  [15]潘锟镭,刘刚,马晓东,等 . 疏风解毒胶囊治疗风热证型社区
               and national age-sex specific all-cause and cause-specific mortality   获得性肺炎疗效观察及对细胞因子的影响[J]. 中华中医药杂
               for 240 causes of death,1990—2013:a systematic analysis for the   志,2020,35(6):3224-3226.
               Global Burden of Disease Study 2013[J]. Lancet,2015,385   PAN K L,LIU G,MA X D,et al. Observation of Shufeng Jiedu
               (9963):117-171. DOI:10.1016/S0140-6736(14)61682-2.   Capsules in the treatment of wind-heat syndrome community
           [5]WUNDERINK R G,WATERER G. Advances in the causes and   acquired pneumonia and its effects on cytokines[J]. China Journal
               management of community acquired pneumonia in adults[J].   of Traditional Chinese Medicine and Pharmacy,2020,35(6):
               BMJ,2017,358:j2471. DOI:10.1136/bmj.j2471.           3224-3226.
           [6]ALIBERTI  S,COOK  G  S,BABU  B  L,et  al.  International   [16]瞿香坤,王其凯,唐超,等 . 疏风解毒胶囊联合抗生素治疗社
               prevalence and risk factors evaluation for drug-resistant Streptococcus   区获得性肺炎的临床观察[J]. 中国中医急症,2019,28(6):
               pneumoniae pneumonia[J]. J Infect,2019,79(4):300-311.   1059-1061. DOI:10.3969/j.issn.1004-745X.2019.06.033.
               DOI:10.1016/j.jinf.2019.07.004.                      QU X K,WANG Q K,TANG C,et al. Clinical observation of
           [7]中华中医药学会内科分会,中华中医药学会肺系病分会,中国                           Shufeng Jiedu capsule combined with antibiotics in the treatment
               民族医药分会肺病分会 . 社区获得性肺炎中医诊疗指南(2018                      of community acquired pneumonia[J]. Journal of Emergency in
               修 订 版)[J].  中 医 杂 志,2019,60(4):350-360. DOI:         Traditional Chinese Medicine,2019,28(6):1059-1061.
               10.13288/j.11-2166/r.2019.04.019.                    DOI:10.3969/j.issn.1004-745X.2019.06.033.
               Internal Medicine Branch of China Association of Chinese Medicine,  [17]汪周华 . 疏风解毒胶囊治疗社区获得性肺炎的疗效分析[J].
               Lung Disease Branch of China Association of Chinese Medicine,  世 界 中 医 药,2016,11(8):1510-1512,1516. DOI:
               Lung Disease Branch of China Medical Association of Minorities.   10.3969/j.issn.1673-7202.2016.08.032.
               Guidelines for the diagnosis and treatment of community-acquired   WANG Z H. Efficacy analysis of Shufeng Jiedu capsule in treating
               pneumonia(2018 revision)[J]. Journal of Traditional Chinese   community-acquired pneumonia[J]. World Chinese Medicine,
               Medicine,2019,60(4):350-360. DOI:10.13288/j.11-      2016,11(8):1510-1512,1516. DOI:10.3969/j.issn.1673-
               2166/r.2019.04.019.                                  7202.2016.08.032.
           [8]七成中成药由西医医师开出:专家呼吁制定西医中成药临床使                      [18]王波太 . 疏风解毒胶囊联合莫西沙星治疗社区获得性肺炎的
               用指南[J]. 中华全科医师杂志,2012,11(7):506.                     疗效观察[J]. 实用临床医药杂志,2020,24(19):41-44.
           [9]中华医学会呼吸病学分会 . 中国成人社区获得性肺炎诊断和治                         DOI:10.7619/jcmp.202019012.
               疗指南(2016 年版)[J]. 中华结核和呼吸杂志,2016,39(4):               WANG  B  T.  Efficacy  of  Shufeng  Jiedu  Capsule  combined
               253-279.                                             with  moxifloxacin  in  the  treatment  of  community-acquired
           [10]HIGGINS J P T,ALTMAN D G,GØTZSCHE P C,et al. The     pneumonia[J]. Journal of Clinical Medicine in Practice,2020,
               Cochrane Collaboration's tool for assessing risk of bias in randomised   24(19):41-44. DOI:10.7619/jcmp.202019012.
               trials[J]. BMJ,2011,343:d5928. DOI:10.1136/bmj.d5928.   [19]魏兵,周玉涛,陈玉,等 . 疏风解毒胶囊联合抗生素治疗社区
   112   113   114   115   116   117   118   119   120   121   122